National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2011 (No. 1) (No. PB 11 of 2011) (Cth)
PB 11 of 2011
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2011
(No. 1)1
National Health Act 1953
I, FELICITY McNEILL, Acting First Assistant Secretary, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under sections 84AF, 85, 85A, 88 and 101 of the National Health Act 1953.
Dated 20 January 2011
FELICITY McNEILL
Acting First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
1 Name of Instrument
(1) This Instrument is the National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2011 (No. 1).
(2) This Instrument may also be cited as PB 11 of 2011.
2 Commencement
This Instrument commences on 20 January 2011.
3 Amendment of PB 108 of 2010
Schedule 1 amends PB 108 of 2010.
Schedule 1 Amendments
[1] Schedule 1, entry for Ciprofloxacin in the form Tablet 250 mg (as hydrochloride)
omit from the column headed “Circumstances” (all instances):
C1143 C1431 C1432 C1572 C1573
insert:
C1143 C1431 C1432 C1572 C1573 C3680
[2] Schedule 1, entry for Ciprofloxacin in each of the forms: Tablet 500 mg (as hydrochloride); and Tablet 750 mg (as hydrochloride)
omit from the column headed “Circumstances” (all instances):
C1431 C1432 C1572 C1573
insert:
C1431 C1432 C1572 C1573 C3680
[3] Schedule 4, Part 1, entry for Ciprofloxacin
insert after existing text in the columns in the order indicated:
| C3680 | For use in skin or soft tissue infections (wound management) where other antimicrobial agents are ineffective or inappropriate | Compliance with Authority Required procedures |
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.
See
0
0
0